EX-2.1
from 8-K
148 pages
Agreement and Plan of Merger Among: Ocuphire Pharma, Inc. a Delaware Corporation; Orange Merger Sub I, Inc., a Delaware Corporation; Orange Merger Sub II, LLC, a Delaware Limited Liability Company; and Opus Genetics Inc. a Delaware Corporation Dated as of October 22, 2024
12/34/56
EX-2.1
from 10-Q
109 pages
Agreement and Plan of Merger and Reorganization Among: Rexahn Pharmaceuticals, Inc., a Delaware Corporation; Razor Merger Sub, Inc., a Delaware Corporation; and Ocuphire Pharma, Inc. a Delaware Corporation Dated as of June 17, 2020
12/34/56
EX-2.1
from 425
108 pages
Agreement and Plan of Merger and Reorganization Among: Rexahn Pharmaceuticals, Inc., a Delaware Corporation; Razor Merger Sub, Inc., a Delaware Corporation; and Ocuphire Pharma, Inc. a Delaware Corporation Dated as of June 17, 2020
12/34/56
EX-2.1
from 8-K
108 pages
Agreement and Plan of Merger and Reorganization Among: Rexahn Pharmaceuticals, Inc., a Delaware Corporation; Razor Merger Sub, Inc., a Delaware Corporation; and Ocuphire Pharma, Inc. a Delaware Corporation Dated as of June 17, 2020
12/34/56